TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Lemongrass Medical Consulting&Invest AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
740
|
1,324
|
1,393 |
| Financial expenses |
9
|
6
|
10 |
| Earnings before taxes |
27
|
-98
|
223 |
| EBITDA |
36
|
-94
|
233 |
| Total assets |
138
|
252
|
351 |
| Current assets |
53
|
167
|
266 |
| Current liabilities |
287
|
431
|
432 |
| Equity capital |
-149
|
-179
|
-81 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-108.0%
|
-71.0%
|
-23.1% |
| Turnover per employee |
740
|
1,324
|
1,393 |
| Profit as a percentage of turnover |
3.6%
|
-7.4%
|
16.0% |
| Return on assets (ROA) |
26.1%
|
-36.5%
|
66.4% |
| Current ratio |
18.5%
|
38.7%
|
61.6% |
| Return on equity (ROE) |
-18.1%
|
54.7%
|
-275.3% |
| Change turnover |
-584
|
-69
|
-21 |
| Change turnover % |
-44%
|
-5%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.